Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1973 1
1977 1
1978 1
1979 1
1987 1
1988 1
1996 5
1997 2
1998 2
2000 1
2001 2
2002 1
2003 2
2004 2
2005 2
2006 1
2007 6
2008 9
2009 11
2010 12
2011 12
2012 16
2013 12
2014 18
2015 17
2016 23
2017 22
2018 29
2019 22
2020 25
2021 28
2022 20
Text availability
Article attribute
Article type
Publication date

Search Results

260 results
Results by year
Filters applied: . Clear all
Page 1
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.
Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, Confer DL, Eapen M, Fernandez-Vina M, Hartzman R, Maiers M, Marino SR, Mueller C, Perales MA, Rajalingam R, Pidala J. Dehn J, et al. Among authors: spellman s. Blood. 2019 Sep 19;134(12):924-934. doi: 10.1182/blood.2019001212. Epub 2019 Jul 10. Blood. 2019. PMID: 31292117 Free PMC article. Review.
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.
D'Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, Devine S, Eapen M, Hamadani M, Hari P, Pasquini MC, Perez W, Phelan RA, Riches ML, Rizzo JD, Saber W, Shaw BE, Spellman SR, Steinert P, Weisdorf DJ, Horowitz MM. D'Souza A, et al. Among authors: spellman sr. Biol Blood Marrow Transplant. 2020 Aug;26(8):e177-e182. doi: 10.1016/j.bbmt.2020.04.013. Epub 2020 May 11. Biol Blood Marrow Transplant. 2020. PMID: 32438042 Free PMC article. Review.
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Fuchs EJ, McCurdy SR, Solomon SR, Wang T, Herr MR, Modi D, Grunwald MR, Nishihori T, Kuxhausen M, Fingerson S, McKallor C, Bashey A, Kasamon YL, Bolon YT, Saad A, McGuirk J, Paczesny S, Gadalla SM, Marsh SGE, Shaw BE, Spellman SR, Lee SJ, Petersdorf EW. Fuchs EJ, et al. Among authors: spellman sr. Blood. 2022 Mar 10;139(10):1452-1468. doi: 10.1182/blood.2021013443. Blood. 2022. PMID: 34724567
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
Lindsley RC, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu ZH, Spellman SR, Lee SJ, Verneris MR, Hsu K, Fleischhauer K, Cutler C, Antin JH, Neuberg D, Ebert BL. Lindsley RC, et al. Among authors: spellman sr. N Engl J Med. 2017 Feb 9;376(6):536-547. doi: 10.1056/NEJMoa1611604. N Engl J Med. 2017. PMID: 28177873 Free PMC article.
HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation.
Petersdorf EW, Stevenson P, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Carrington M. Petersdorf EW, et al. Among authors: spellman sr. Blood. 2020 Jul 16;136(3):362-369. doi: 10.1182/blood.2020005743. Blood. 2020. PMID: 32483623 Free PMC article.
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.
Shaw BE, Jimenez-Jimenez AM, Burns LJ, Logan BR, Khimani F, Shaffer BC, Shah NN, Mussetter A, Tang XY, McCarty JM, Alavi A, Farhadfar N, Jamieson K, Hardy NM, Choe H, Ambinder RF, Anasetti C, Perales MA, Spellman SR, Howard A, Komanduri KV, Luznik L, Norkin M, Pidala JA, Ratanatharathorn V, Confer DL, Devine SM, Horowitz MM, Bolaños-Meade J. Shaw BE, et al. Among authors: spellman sr. J Clin Oncol. 2021 Jun 20;39(18):1971-1982. doi: 10.1200/JCO.20.03502. Epub 2021 Apr 27. J Clin Oncol. 2021. PMID: 33905264 Free PMC article. Clinical Trial.
The clinical and functional effects of TERT variants in myelodysplastic syndrome.
Reilly CR, Myllymäki M, Redd R, Padmanaban S, Karunakaran D, Tesmer V, Tsai FD, Gibson CJ, Rana HQ, Zhong L, Saber W, Spellman SR, Hu ZH, Orr EH, Chen MM, De Vivo I, DeAngelo DJ, Cutler C, Antin JH, Neuberg D, Garber JE, Nandakumar J, Agarwal S, Lindsley RC. Reilly CR, et al. Among authors: spellman sr. Blood. 2021 Sep 9;138(10):898-911. doi: 10.1182/blood.2021011075. Blood. 2021. PMID: 34019641 Free PMC article. Clinical Trial.
HLA-DQ heterodimers in hematopoietic cell transplantation.
Petersdorf EW, Bengtsson M, Horowitz M, McKallor C, Spellman SR, Spierings E, Gooley TA, Stevenson P; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Petersdorf EW, et al. Among authors: spellman sr. Blood. 2022 May 19;139(20):3009-3017. doi: 10.1182/blood.2022015860. Blood. 2022. PMID: 35271697
Germline predisposition variants occur in myelodysplastic syndrome patients of all ages.
Feurstein SK, Trottier AM, Estrada-Merly N, Pozsgai MJ, McNeely KE, Drazer MW, Ruhle B, Sadera K, Koppayi AL, Scott BL, Oran B, Nishihori T, Agrawal V, Saad A, Lindsley RC, Nakamura R, Kim S, Hu ZH, Sobecks RM, Spellman SR, Saber W, Godley LA. Feurstein SK, et al. Among authors: spellman sr. Blood. 2022 Aug 19:blood.2022015790. doi: 10.1182/blood.2022015790. Online ahead of print. Blood. 2022. PMID: 35969835
State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.
Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL; National Marrow Donor Program. Kamani N, et al. Among authors: spellman s. Biol Blood Marrow Transplant. 2008 Jan;14(1):1-6. doi: 10.1016/j.bbmt.2007.11.003. Biol Blood Marrow Transplant. 2008. PMID: 18158954 Free article. Review. No abstract available.
260 results